logo
Menu

We provide briefings on technologies to different public stakeholders, from those delivering care and research funders stimulating innovation, to policy makers and advisory bodies. Most, if not all of these briefings, will be publicly available on this website via the search window.

Innovation Observatory > Reports > Drugs > Inhaled Lipid‐complexed Cisplatin for Pulmonary Relapse of Osteosarcoma

< Back

Inhaled Lipid‐complexed Cisplatin for Pulmonary Relapse of Osteosarcoma

Drugs

Cancer and Palliative Care

February 2018


Osteosarcoma is a rare cancer affecting the bones. It is also the most common bone cancer in children and young adults but can also occur in older adults. It mostly affects the knee, thigh bone, shin bone or upper arm. Symptoms include pain and swelling around the affected bone. Current treatment options have improved the prognosis of this disease, however, a recurrence of osteosarcoma may appear in other parts of the body after the primary cancer has been treated. The majority of the recurrences occur in the lungs. Symptoms of lung involvement may include cough, breathlessness, pain or discomfort in the chest.
Inhaled Lipid‐complexed Cisplatin or inhaled liposomal cisplatin (ILC) is an anticancer drug being developed for the treatment of osteosarcoma that has reoccurred and spread to the lungs. Cisplatin is already available in the UK as an intravenous injection for treating multiple types of malignant conditions. ILC is administered via inhalation has the potential advantage to deliver the drug directly to the site of action (the lungs) with significantly reduced systemic side effects and toxicities. If licensed, ILC will offer an additional treatment option with the potential to improve effectiveness and safety for patients with pulmonary relapse of osteosarcoma.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Download Full Article



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts

Get Alerts